Soutullo CA, Cottingham EM, Keck PE
[DOI] [PubMed] [Google Scholar] 5.Goossens V, De Vos K, Vercammen D, Steemans M, Vancompernolle K, Fiers W, Vandenabeele P, Grooten J
Many patients describe feeling full sooner, needing smaller portions, or having quieter food noise persistent, intrusive thoughts about food reported by many patients with obesity
Important safety considerations include: Increased hypoglycaemia risk when used with insulin or sulfonylureas (dose adjustments of these medications may be needed) Potential worsening of diabetic retinopathy with rapid improvement in blood glucose control, particularly with semaglutide Need for monitoring in patients with pre-existing retinopathy The MHRA continues to monitor the safety profile of these agents
To streamline your care, we allow for early coverage determination starting 12/1/2025 as along as your eligibility is on file
NEJM American Urological Association